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The Changing Face of Civil Aviation Medicine, Part I
Rapid Growth, Terrorists Force Early Transition
BY CHARLES E. BILLINGS, MD, THE OHIO STATE UNIVERSITY
Iwas better prepared for this talk before September 11 than I am now. I am very unsureabout the future face even of civil aviation, given its use as a tool by the terrorists, butI will be surprised if there is no fallout for many or all support activities like ours as we
move toward a partial war footing. I don't believe changes in civil aviation will be nearly as
drastic as those in the second World War; the nation is too dependent on aviation as its
primary long-distance transportation medium. I do think that the rapidity of expansion
may ease for a time and that there will be a substantial decline in traffic in the short run.
The unrelenting demand for air services powder horns and we had gone well beyond
has been a major source of pressure on the
people who operate and maintain the avia-
tion system, and this may ease for a time,
though massive layoffs already underway are
likely to make things still more difficult for
those who are left in place. It would be help-
ful if lessened demand could ease the diffi-
culties under which many controllers, pilots,
cabin crew and maintenance personnel are
presently laboring. Such a cut in demand
might even give the FAA at least a few
months of relief from constant demands for
radical system changes that it cannot and
should not accommodate. If that were to
happen, it could be beneficial for FAA man-
agement and staff in the short term, and
perhaps for the entire aviation community
and enterprise in the longer term.
A long-term trend toward relaxation of
medical standards has been evident since
shortly after World War II. Some civil and
more military pilot standards were difficult
to justify even then. George Kidera loved to
cite the Air Corps disqualification for mal-
occlusion, a standard promulgated initially
to ensure that soldiers were able to pull the
cork from their powder horns with their
teeth. The fact that military pilots rarely used
muzzle loaders in air warfare had escaped
the Air and Medical Staffs for over 30 years.
Similarly, military physicians were slow to
realize that the venerable Schneider Test, a
selection procedure that evaluated cardiovas-
cular and respiratory fitness, was easiest to pass
if taken in the midst of a major hangover. This
Continued on page 4
Call for Papers
Your editor is searching for your in-
put into the CAMA F//gArPhysician.
Needed is an interesting, challenging,
problematic, worrisome, or delaying
pilot certification case. All FAA Avia-
tion Medical Examiners and CAMA
physicians experience pilot applicants
by the "thousands!" Are there occasions
that develop in your contact with these
flyers that fit a picture that would be
of interest to your fellow examiners?
Share your memorable cases —short
notes or long dissertations! Full credit
will be given —or anonymity, if that is
your desire.
—Jim Almand
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The President's Musings
BY ROBIN DODGE, MD
DR. ALMAND HAS EXPENDED alarge amount of time and ef-
fort to get the FlightPhysician back
on track and trending toward six
publications per year. His actions
deserve both support and recognition. I hope that you,
the membership, will let him know that his efforts are
appreciated. I should point out that the byline for the
"sport pilot plot" article, on page four of the last
FlightPhysician, actually belongs to Dr. Almand, and is
not mine. It was written as a summary of the type of
comments CAMA members submitted in response to the
survey placed on our Web site and in the last FlightPhysician.
The NPRM on sport flying quoted statistics for medi-
cally-related events as being an extremely small number
of such accidents. I seem to recall that, in similar statis-
tics that I have seen over the years, a large percentage of
these type of accidents are caused by a condition for which
the medical monitoring system was not made aware. It
can then be inferred that the medical screening is essen-
tially doing its job. This appears to be the situation around
the world. This perception can be studied. There is a
tremendous volume of epidemiological data contained
within the world's pilot medical certification and acci-
dent investigation databases. This data should be con-
tinually mined to correlate the effectiveness of medical
standards. The same mined data could also be used to
formulate a scientific basis for medical standard develop-
ment and implementation. One area that could be ad-
dressed is the question: Are different classes of medical
certificates necessary?
Assuming a truly scientific approach was undertaken
to examine the medical certification issue, there still re-
mains the divergence of personal and/or agency philoso-
phies in applying the scientific knowledge. This fact was
reinforced by the exchange between panelists and audi-
ence members at the CAMA Sunday session in Montreal.
As an example, the issue of requiring EEGs as part of the
pilot medical revealed polar philosophies, despite the
knowledge that a significant number of EEGs in a ran-
dom population would result in non-pathologic EEG
changes. All these false positives would require a work-
up to determine pilot fitness. Consequently, the question
"what is the base level of health/physical/mental fitness
necessary for anyone to safely act as a pilot in command?"
needs to be addressed uniformly based on today's medical
knowledge and pilot medical certification experiences.
Have a happy and safe summer
fP
Diabetes and Flyers
EDITORIAL, BY JAMES R. ALMAND, MD
OVER MANY YEARS it has been fascinating to observeaviation medicine's changing direction by the CAA
(now the FAA). In earlier times, one-eyed or one-legged
or no-legged or no-hands (?) pilots were certified (and
still are). Now also, post-myocardial infarct and bypass
pilots are certifiable for return to flight with today's care-
ful medical guidance. All the above pilots flew with little
occurrence of adverse events. But, more significantly, were
there any occurrences of critical or devastating aviation
safety problems to these aviators from their disabilities?
Not really.
Most recently, the subject of a diabetic pilot flying under
insulin control in our airspace with FAA medical certifi-
cation emerged. This discussion of an insulin-dependent
pilot certification was widely and loudly condemned by
many aviation medical authorities as "heresy" and lack-
ing in both aviation and medical scientific basis. But in
1998 the first medical FAA certification of an insulin-
dependent diabetic followed. Today, there are 30 diabetic
pilots under insulin control in the air.
Surely, these diabetics must maintain proof of opti-
mum glycemic control in pre-, during-, and post-flight
times (by careful monitoring of blood sugars) but through
careful insulin management these flyers are allowed to
serve as pilot in command with class III FAA certification.
Is the FAA's medical director, Jon Jordan, MD, a vi-
sionary by taking steps to meet his flying public's "special
medical interest groups" for continuing (or beginning)
flight? Well, perhaps, but let's give joint credit also to Dr.
Jordan's (and FAA's) expert team of medical specialty ad-
visors, upon whom he continually relies for balanced opin-
ions and direction. And that is as it should be in all facets
of our medical science!
Where does this leave us today? Our monocular, am-
putee, recovering alcoholics, ex-drug dependent, diabetic,
HIV, lymphoma, and cardiac are all doing well in the air
and proving to us and the FAA that they (and also we)
were right in their certification.
Where is the next Mount Everest the AME and the
FAA will climb? Keep tuned! FP
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Fatigue: The Hidden Culprit
BY PAUL LILLY, MD, MPH
"BOY, IS THE TRAFFIC EVER HEAVY....
thought it would have thinned out a bit
this late in the day. I need to get to the
airport and get airborne before the
weather closes in any more."
BEEP.... BEEP.... BEEP
"That looks like my partner's num-
ber. Sure hope Mr. Smith is not bleed-
ing again. He was sure pouring it out at
2:00 this morning in the ER."
Way back about 1940, human fac-
tors only accounted for some 20% of
accidents, with mechanical factors con-
tributing the other 80%. Now the ratio
is reversed with human factors contrib-
uting 80%. What a reversal!
A few years ago NASA made the de-
cision to launch the space shuttle Chal-
lenger, despite freezing weather and af-
ter working 20 hours straight. The re-
sults were catastrophic!
An airliner flying across the Pacific
drifted into Canadian airspace. There
was no response to repeated radio calls,
so Canadian Air Force jets scrambled to
intercept. They finally awoke the crew
by shining bright lights into the cock-
pit! And we all recognize the fact that
drivers frequently fall asleep at the wheel
with non too good results. Fatigue, fa-
tigue, fatigue!
Symptoms of fatigue commonly
manifest as complacency, slowed reac-
tion times, difficulty making decisions,
impaired coordination, moodiness, de-
pression, lowering of standards and
blaming others for our errors.
Factors causing stress are many. How
is your practice going — economically,
interpersonally, medically? Is your fam-
ily OK? Is your partner cheating on you?
Are there any serious health problems
in the family? How much rest are you
getting between family, practice, flying,
hobbies, etc.? Any substance abuse?
How's your daughter's wedding coming
along? What's the state of your credit
cards post-Christmas? Had any "I al-
most bought the farm" experiences
while flying?
So, who told you that you had to
make this trip tonight? And you really
must go?
Just like our physician pilot above who
has been in the ER and office, and now
is rushing to get airborne in question-
able weather, there are many factors that
stress us into dangerous fatigue. But...
we're physicians, we are used to it, we
can handle it? Well, maybe a bit, but we
are still subject to the laws of human
frailty. Many times we should not be
treating patients, let alone flying a com-
plex aircraft. Just because you can afford
a complex, high-performance, highly
equipped machine does not mean that it
will allow you to fly in such a fatigued
state. In fact, all the gadgets probably
make more demands on you.
How do you deal with this? First de-
fine the problem. Who the heck caused
all this in the first place? Answer: Look
in a mirror. Evaluate your resources and
see what solutions are available. Go to-
morrow—or swallow your ego and take
the airline (they probably fly a bit more
than you, and there is more than one pi-
lot on the flight deck). Make a sensible
choice and do it!
And finally, what is the "cure?" Stay
in good physical condition. Don't abuse
your body. Get adequate recreation, sleep,
and maintain good nutrition. Discipline
yourself. After all, this is what we tell our
patients, isn't it?
Doctor, heal thyself.
Here's to safe flying.
Check six. fP
Dr. Lilly has the pilot ratings of ATP, CFII,
andASMEL.
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CAMA CONSULTANTS
To our new members and as a reminder to all: This is a list of more experienced AMEs that have volun-
teered to help with troublesome certification cases. For involved questions, e-mail or fax is preferred. This list
is NOT for use by airmen, but solely for AMEs within the CAMA membership.
Frank H. Austin, MD EST
Phone: 703- 471-1769 Fax: 703-450-3104
E-mail: FHAustin@aol.com
Charles A. Berry, MD CST
Phone: 713-978-7755 Fax: 713-978-5001
E-mail: docchuckb@aol.com
A. Duane Catterson, MD CST
Phone: 281-873-0111 Fax: 281-873-0660
E-mail: cattersib@worldnet.att.net
Marc C. Eidson, MD CST
Phone: 817-599-9472 Fax: 817- 599-9472
E-mail: MARK@EIDSON.ORG
A. J. Parmet, MD CST
Phone: 816-561-3480 Fax: 816-561-4043
E-mail: AJParmet@cysource.com
Gordon L. Ritter, DO MST
Phone: 520-776-9830 Fax: 513-751-5660
E-mail: gordon@rittaire.com
Robert A. Stein, MD EST
Phone: 513-751-0080 Fax: 513-751-5660
E-mail: Bobxtein47@aol.com
M. Young Stokes III, MD CST
Phone 903-465-6707 Fax: 903-465-6744
E-mail: mysiii@flash.net
James L. Tucker, MD EST
Phone: 256-329-7788
E-mail: JLTucker@mindspring.com
MarkThoman.MD CST
Phone: 515-244-4229 Fax: 515-244-1131
E-mail: PARO1795@aol.com
John D. Hastings, MD CST
Phone: 918-747-7517 Fax: 918-742-7947
E-mail: hastings20@msn.com
H. Stacy Vereen, MD EST
Phone: 404-761-2166 Fax: 404-761-2168
E-mail: Stacyv@earthlink.net
CHANGING FACE from page 1
was fairly common knowledge among pilot candidates
and there is no way of knowing how many made use of
that knowledge to improve their scores. It probably didn't
matter too much, since the Schneider procedures didn't
really measure what they were supposed to and the test
was dropped after the war.
Our States often aver that automobile driving is a privi-
lege rather than a right or entitlement. But the Federal
Aviation Act of 1958 firmly declared, on behalf of all US
citizens, the "right of transit of the navigable airspace,"
and this has always been taken to mean that any citizen
may become a pilot unless he or she is unable to pass a
flight medical or flight proficiency examination. Pilot rep-
resentative organizations take this very seriously, and dur-
ing the past 20 years there have been almost constant
demands for relaxation, or outright elimination, of vari-
ous medical standards. The Federal Air Surgeon and his
staff have responded to as many of these demands as they
could, which in turn has led to ramping up pressure for
still further relaxation of, or exemptions from, the medi-
cal standards that remain.
I am not entirely averse to this trend toward relaxation
of certain standards. I believe that one of my patients was
the first person medically certified after being diagnosed
with familial periodic paralysis. We did a full work-up,
reproduced the symptoms in the hospital, then pointed
out to Dr. Davis that if he woke up paralyzed, he wasn't
going to fly that day, and if he wasn't paralyzed when he
woke up in the morning, he wasn't going to be during
the remainder of that day. Nonetheless, I realized very
early in my career that certain truisms taught to me in
medical school did not necessarily apply to the practice of
aviation medicine. One truism was that a patient and a
physician act as a team in discovering, diagnosing, and
treating the patient's diseases.
We had a crash call one night in 1955 when I was
Medical Officer of the Day at an air base in England.
When I arrived at the site, I learned that the Aerodrome
Concluded next page
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Officer of the Day had failed to respond to the call.
He was one of my patients, a quiet but effective chap
and a good fighter pilot on whom I had done a physi-
cal a short time before. After things quieted down and
I was able to sit down with Lieutenant X, I asked why
he hadn't shown up at the crash call. He was unable to
answer the question, but stated that he was afraid of
what he might find. He said he knew that he was men-
tally ill; he could no longer carry on in the face of
derogatory remarks all the other pilots made about him.
He had overheard "everyone" making similar remarks
through pilot training and transition school. The voices
accused him of sexual and other misdeeds, which he
denied. When asked whether he ever heard such voices
while flying, he stated almost indignantly that it cer-
tainly wasn't possible to hear voices through a sealed
canopy! He had some superficial insight, though he
was unaware that the voices he heard were unreal. He
was evacuated to the United States with the diagnosis
of schizophrenia.
I learned that night that a flight surgeon is power-
less unless or until his patients choose to confide in
him. During my two years at that air base, I also learned
that there are many reasons why pilots may choose not
to be up front even with a physician they know well
and respect. In the years since, this lesson has been
brought home to me hundreds of times, as I'm sure it
has to many of you. Without an honest and forthright
medical history, you will miss much of importance in
your evaluation of apparently healthy aviators, who may
have much to lose, and in their minds nothing to gain,
by being truthful with you.
Why do I dwell on this? Is it really all that impor-
tant? Well, my young Lieutenant was flying an air-
plane on alert with 24 2.75" live rockets. Fortunately,
his paranoid ideation was never focused on specific
people, though he was certainly actively psychotic. I
knew him well, but I didn't know that until he told
me. Would you know if your pilot was a reasonably
well-controlled diabetic taking insulin, if he wasn't gly-
cosuric when he gave you a sample? I didn't know about
a retired Brigadier General who was my patient, until
he decompensated one day and finally told me why he
was in serious trouble. Would you know if an exam-
inee had paroxysmal supraventricular tachycardia, but
a normal sinus rhythm the rest of the time, including
when you examined him? Or, for that matter, familial
periodic paralysis, if the pilot hadn't chosen to tell you
about it and ask for help? Or a pilot who was taking
any of a hundred medications or herbal preparations?
Our pilots are getting older, and are much more
likely to be taking medications, simply because there
are more effective medications they can take for what-
ever conditions they may have. They can take some
without prescriptions, and lots of herbals, some of
which are not benign, as was pointed out in a recent
excellent article in Aviation, Space & Environmental
Medicine. I am in favor of relaxing standards— but
how much is too much?
The FAA has relaxed other standards too; ATC sepa-
ration minimurns in terminal areas have gone from 5
miles to 3 miles, to "no merging targets" to increase
system throughput in the face of constantly increasing
demand. We are also seeing reduced vertical separa-
tion minimums, from 2000 to 1000 ft. above flight
level 290. How little separation is too little?
You can't answer these questions analytically. The
only way to approach them is empirically, by sneaking
up on them. That's what has been done, thus far suc-
cessfully, with terminal area separation minima. But
we have to recognize that bad outcomes are rare in a
well-organized system. So it may be quite awhile be-
fore something really scary happens, even if we have
increased the probability of a bad outcome from .001
to, say, .01, or more likely from .0001 to .001.
You've sort of done this in your recent actions con-
cerning the Age-60 rule. I disagree with your position,
because I have experienced some of the cognitive ef-
fects of aging that can interfere with safe flying, and
because I know how easy it is to hide many medical
conditions that can also interfere with safe flying. But
you have articulated a more relaxed position, and if it
is endorsed, I sincerely hope that it doesn't come back
to bite us. Dr. Nakagawara published in July a CAMI
report on aviation accidents and incidents associated
with the use of ophthalmic devices by civil pilots. He
found 15 accidents, only one in air transport, and 27
incidents. Given that 54% of pilots require ophthalmic
devices, including me, I'm not about to suggest that
we have relaxed our vision standards too much—but
even this very good piece of research doesn't help us to
know how much is too much. /P
This concludes the first installment of a two-part-
article. The conclusion will be in the next issue of the
FlightPhysician. The text was prepared for the Civil Avia-
tion Medical Association scientific meeting, Atlanta, Ga.,
October 11, 2001. © Charles E. Billings, MD, 2001.
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New Members
CAMA welcomes these new members to our growing family of aeromedical colleagues
Charles F. Albert, MD
210 Indian Springs Dr.
Florence, AL 35634-4605
P- 256-389-9693 F- 256-386-4605
Internal Medicine AME
Nasser Al-Nuaimi, MD
P.O. Box 17151
Al-Ain, United Arab Emirates
P-971-50-6234500 F- 97124056507
Aviation Medicine AME
Nader Al-Safar, MD
Medical Care Centre
Shaikh Duaij Ave., PO Box 20264
Gudaibiya, Bahrain
P-710066 F-9443155
Aviation Medicine Pilot, AME
Elena Antonelli, MD
2636 Bristol Pike
Bensalem, PA 1902-5366
P- 215-639-8770 F- 215-639-8771
Occupational Medicine AME
Daniel H. Bolin, MD
1208 Brook
Wichita Falls, TX 76301-5602
P- 940-761-3333 F- 940-766-6302
Occupational Medicine Pilot, AME
Henry K. Boren, DO
P.O. Box 390
Holdenville, OK 74848-0390
P- 405-379-6080
Aviation Medicin AME
James R. Carlson, MD
310 N. Wilmot Road, Suite 206
Tucson, AZ 85711-2618
P- 520-760-8777 F- 520-885-6388
ENT Pilot, AME
Richard E. Carlson, MD
509 Cavalier Drive
Virginia Beach, VA 23451-3833
P- 757-424-3998 F- 757-466-7616
Ophthomology Pilot, AME
Richard A. Craven, MD
1821 Old Donation Parkway, #12
Virginia Beach, VA 23454-3033
P- 757-481-9406 F- 757-481-5549
Occupational Medicine AME
Jeffrey H. Dysart, MD
3303 Ruffin Road, Suite F
San Diego, CA 92123-4087
P-858-277-0082 F-858-277-8738
Family Practice Pilot, AME
David L. Elliott, MD
18404 N. Tatum Blvd., #205
Phoenix, AZ 85032-1095
P-602-971-5500 F-602-944-0181
Internal Medicine AME
Joseph G. Fortunate, DO
38 Brirewood Lane
Silver City, NM 88061-8659
P- 505-534-4830
Family Practice Pilot, AME
Greg Fuller. MD
109 North Elm Avenue
Jackson, MI 49202-3501
P- 517-784-6663 F-517-787-7976
Emergency Medicine Pilot, AME
Laura G. Gillis, MD
109 Katie Lane
Winchester, VA 22602-6664
p. 540-542-1909
Occupational Medicine AME
Richard S. Gist, MD
Dept. of OB/GYN
5825 Airline Highway
Baton Rouge, LA 70805-2408
P-225-358-1179 F-225-358-1076
Urology AME
George W. Griffith, MD
P.O. Box 609
Mt. Vernon, KY 40456-0609
P-601-256-2961 F-601-256-3561
Family Practice Pilot, AME
Fayyaz Haq, MD
Piedmont Physician Group
105 Collier Road, Suite 2070
Atlanta, GA 30345-2070
P-404-350-3860 F-404-609-7660
Internal Medicine AME
Thomas F. Hattar, MD
2009 Tidewater Colony Drive
Annapolis, MD 21401
P- 410-224-0010 F- 410-224-0012
Internal/Occupational Medicine AME
Ahmed M. Jad, MD
P.O. Box 25100
Riyadh, Saudi Arabia, 11466
966-14915159 F-966-14935179
Aviation Medicine AME
Daniel T Johnston, MD
9088 Caribbean Drive
Pensacola, FL 32506-7247
P-850-516-3783
Aviation Medicine Pilot, AME
Stephen M. Kramer, DO
10025 Rearwin Lane, Aero County Ap
McKinney, TX 75071
972-346-9007 F-972-540-1106
Internal/Aviation Medicine Pilot, AME
Lora Lari-Castrillon, MD
AV. Redictp 1580. Dep. 105
Lima, Peru 18
p-Ol 1-51-1-447-4684
Internal Medicine AME
Ronnie C. Marrache, MD
109 Silver Street
Waterville, ME 04901-5923
207-872-0866 F-207-872-8098
Internal Medicine Pilot, AME
Gaines C. Martin, MD
768 Arran Court
Orange Park, FL 32073-8410
P-904-213-0556 F-904-778-4200
Family Practice Pilot, AME
Geoffrey W. McCarthy, MD
50 Tamarack Drive
Delmar, NY 12054
p. 518-478-9116
Aviation Medicine Pilot, AME
Daniel Kirunda Misango, MD
P.O. Box 3817
Kampala, Uganda
P- 256-75-695677
Aviation Medicine Pilot, AME
Eduin Muniz, MD, PhD
809 East Bloomingdale Avenue, #421
Brandon, FL33511
P-813-814-3380 F-813-814-3380
Aviation Medicine Pilot, AME
Continued on page 11
STEREO OPTICAL, A TRUSTED NAME IN
VISION SCREENING FOR OVER 50 YEARS.
OPTE(f 2000/2500 VISION TESTER FEATURES
Forehead Rest Pressure Bar
Ensures proper patient position.
(Includes disposable forehead tissues.)
Controlled Lighting
For the most accurate
color vision testing
available.
Peripheral Test (Optional)
Test vision on a horizontal
plane. Stimuli at 85, 70,
and 55 degrees temporal
and nasal.
Distance/Near Lens Systems
Two separate testing ports
for accurate distance and near testing.
Test at 32 inches for
intermediate testing.*
Lightweight, Portable
Bulk in handle for easy
transport.
Side Access Doors
For easy patient/instructor
interaction.
Near/Far Point Indicators
Illuminates at proper position
to verify test selection.
Tilt Activator
Height adjustable to
accommodate all patients.
RAJL TEST PACKAGE
SLIDE # 1 Peripheral Test Slide
SLIDE # 2** Distance Letter Acuity Monocular/Binocular (20/200-20/20)
SLIDE # 3** Pseudoisochromatic Color Perception
SLIDE # 4** Near Letter Acuity Monocular/Binocular (20/100-20/20)
SLIDE # 5** Lateral Phoria (1 Diopter Increments)
SLIDE # 6** Vertical Phoria (1/2 Diopter Increments)
SLIDE # 7 Stereo Depth Perception (400-20 Seconds of Arc)
SLIDE # 8 Fusion
SLIDE # 9 Distance Tumbling "E" Acuity Monocular/Binocular (20/200-20/20)
SLIDE #10 Tumbling "E" Color Perception
SLIDE #11 Muscle Balance (Combination Lateral & Vertical Phoria)
SLIDE #12 Distance Allen Test (20/100-20/30)
* This is a requirement for all airmen over the age of 50.
** These tests are required for F.A.A. vision exam.
Optoc » a regwOrw trademark of Steno Optical Co.. Inc., Chicago. IL
Optec 2500 Vmon Inter is manuKcturad ixxtor US Patent HU 452 515
rgic rhinitis (SAR) and perennial allergic rhinitis (PAR)
in patients 12 years of age and older, as well as for the symptomatic relief of pruritus, reduction in the number
of hives, and size of hives, in patients with chronic idiopathic urticaria (CIU) 12 years of age and older
When treating SAR, PAR, and CIU, prescribe...
owerful reli he 24th hour
R /^ t
0^tacf/W <c
X^ N
With an excellent safety profile
I Nonsedating—no precautions regarding activities
requiring mental alertness
I Safe for use in seasonal allergic rhinitis patients
with concomitant mild to moderate asthma
I No clinically relevant drug interactions or effects on QTC
— In studies with erythromycin, ketoconazole, azithromycin,
fluoxetine, and cimetidine
I Neither food nor grapefruit juice affected bioavailability
I The FAA medically qualifies pilots and air traffic controllers
using the product under special conditions
In allergic rhinitis, the most commonly reported adverse In chronic idiopathic urticaria, the most common
events included pharyngitis (4.1 %, placebo 2.0%), reported adverse events included headache
dry mouth (3.0%, placebo 1.9%), and fatigue (2.1%, (14%, placebo 13%), nausea (5%, placebo 2%),
placebo 1.2%). and fatigue (5%, placebo 1 %).
(desioratadine) 5mgTABLETS
Please see brief summary of Prescribing Information on following page.
CLARINEX®
(desloratadine)
TABLETS
Brief Summary (For full Prescribing Information, see package insert.)
INDICATIONS AND USAGE: Allergic Rhinitis: CLARINEX Tablets 5 mg are indicat-
ed for the relief of the nasal and non-nasal symptoms of allergic rhinitis (seasonal
and perennial) in patients 12 years of age and older.
Chronic Idiopathic Urticaria: CLARINEX Tablets are indicated for the symptomatic
relief of pruritus, reduction in the number of hives, and size of hives, in patients with
chronic idiopathic urticaria 12 years of age and older.
CONTRAINDICATIONS: CLARINEX Tablets 5 mg are contraindicated in patients
who are hypersensitive to this medication or to any of its ingredients, or to lorata-
dine.
PRECAUTIONS: Carcinogenesis, Mutagenesis, Impairment of Fertility: The car-
cinogenic potential of desloratadine was assessed using loratadine studies. In an
18-month study in mice and a 2-year study in rats, loratadine was administered in
the diet at doses up to 40 mg/kg/day in mice (estimated desloratadine and deslor-
atadine metabolite exposures were approximately 3 times the AUC in humans at the
recommended daily oral dose) and 25 mg/kg/day in rats (estimated desloratadine
and desloratadine metabolite exposures were approximately 30 times the AUC in
humans at the recommended daily oral dose). Male mice given 40 mg/kg/day
loratadine had a significantly higher incidence of hepatocellular tumors (combined
adenomas and carcinomas) than concurrent controls. In rats, a significantly higher
incidence of hepatocellular tumors (combined adenomas and carcinomas) was
observed in males given 10 mg/kg/day and in males and females given
25 mg/kg/day. The estimated desloratadine and desloratadine metabolite exposures
of rats given 10 mg/kg of loratadine were approximately 7 times the AUC in humans
at the recommended daily oral dose. The clinical significance of these findings dur-
ing long-term use of desloratadine is not known.
In genotoxicity studies with desloratadine, there was no evidence of genotoxic
potential in a reverse mutation assay (Salmonella/E. co/i mammalian microsome
bacterial mutagenicity assay) or in two assays for chromosomal aberrations
(human peripheral blood lymphocyte clastogenicity assay and mouse bone marrow
micronucleus assay).
There was no effect on female fertility in rats at desloratadine doses up to
24 mg/kg/day (estimated desloratadine and desloratadine metabolite exposures were
approximately 130 times the AUC in humans at the recommended daily oral dose). A
male specific decrease in fertility, demonstrated by reduced female conception rates,
decreased sperm numbers and motility, and histopathologic testicular changes,
occurred at an oral desloratadine dose of 12 mg/kg in rats (estimated desloratadine
exposures were approximately 45 times the AUC in humans at the recommended
daily oral dose). Desloratadine had no effect on fertility in rats at an oral dose of 3
mg/kg/day (estimated desloratadine and desloratadine metabolite exposures were
approximately 8 times the AUC in humans at the recommended daily oral dose).
Pregnancy Category C: Desloratadine was not teratogenic in rats at doses up to
48 mg/kg/day (estimated desloratadine and desloratadine metabolite exposures
were approximately 210 times the AUC in humans at the recommended daily oral
dose) or in rabbits at doses up to 60 mg/kg/day (estimated desloratadine exposures
were approximately 230 times the AUC in humans at the recommended daily oral
dose). In a separate study, an increase in pre-implantation loss and a decreased
number of implantations and fetuses were noted in female rats at 24 mg/kg (esti-
mated desloratadine and desloratadine metabolite exposures were approximately
120 times the AUC in humans at the recommended daily oral dose). Reduced body
weight and slow righting reflex were reported in pups at doses of 9 mg/kg/day or
greater (estimated desloratadine and desloratadine metabolite exposures were
approximately 50 times or greater than the AUC in humans at the recommended
daily oral dose). Desloratadine had no effect on pup development at an oral dose of
3 mg/kg/day (estimated desloratadine and desloratadine metabolite exposures were
approximately 7 times the AUC in humans at the recommended daily oral dose).
There are, however, no adequate and well-controlled studies in pregnant women.
Because animal reproduction studies are not always predictive of human response,
desloratadine should be used during pregnancy only if clearly needed.
Nursing Mothers: Desloratadine passes into breast milk, therefore a decision
should be made whether to discontinue nursing or to discontinue desloratadine,
taking into account the importance of the drug to the mother.
Pediatric Use: The safety and effectiveness of CLARINEX Tablets in pediatric
patients under 12 years of age have not been established.
Geriatric Use: Clinical studies of desloratadine did not include sufficient numbers
of subjects aged 65 and over to determine whether they respond differently from
younger subjects. Other reported clinical experience has not identified differences
between the elderly and younger patients. In general, dose selection for an elderly
patient should be cautious, reflecting the greater frequency of decreased hepatic,
renal, or cardiac function, and of concomitant disease or other drug therapy, (see
CLINICAL PHARMACOLOGY - Special Populations).
Information for Patients: Patients should be instructed to use CLARINEX Tablets
as directed. As there are no food effects on bioavailability, patients can be instruct-
ed that CLARINEX Tablets may belaken without regard to meals. Patients should
be advised not to increase the dose or dosing frequency as studies have not demon-
strated increased effectiveness at higher doses and somnolence may occur.
ADVERSE REACTIONS: Allergic Rhinitis: In multiple-dose placebo-controlled tri-
als, 2,834 patients received CLARINEX Tablets at doses of 2.5 mg to 20 mg daily,
of whom 1,655 patients received the recommended daily dose of 5 mg. In patients
receiving 5 mg daily, the rate of adverse events was similar between CLARINEX and
placebo-treated patients. The percent of patients who withdrew prematurely due to
adverse events was 2.4% in the CLARINEX group and 2.6% in the placebo group.
There were no serious adverse events in these trials in patients receiving deslor-
atadine. All adverse events that were reported by greater than or equal to 2% of
patients who received the recommended daily dose of CLARINEX Tablets (5.0 mg
once-daily), and that were more common with CLARINEX Tablet than placebo, are
listed in Table 5.
Table 5
Incidence of Adverse Events Reported by > 2% of Allergic Rhinitis
Patients in Placebo-Controlled, Multiple-Dose Clinical Trials
Adverse Experience
CLARINEX Tablets 5 mg Placebo
(n=1,655) (n=1,652)
Pharyngitis
Dry Mouth
Myalgia
Fatigue
Somnolence
Dysmenorrhea
4.1%
3.0%
2.1%
2.1%
2.1%
2.1%
2.0%
1.9%
1.8%
1.2%
1.8%
1.6%
The frequency and magnitude of laboratory and electrocardiograph^ abnormali-
ties were similar in CLARINEX and placebo-treated patients.
There were no differences in adverse events for subgroups of patients as defined
by gender, age, or race.
Chronic Idiopathic Urticaria: In multiple-dose, placebo-controlled trials of chronic
idiopathic urticaria, 211 patients received CLARINEX Tablets and 205 received
placebo. Adverse events that were reported by greater than or equal to 2% of
patients who received CLARINEX Tablets and that were more common with
CLARINEX than placebo were (rates for CLARINEX and placebo, respectively):
headache (14%, 13%), nausea (5%, 2%), fatigue (5%, 1%), dizziness (4%, 3%),
pharyngitis (3%, 2%), dyspepsia (3%, 1%), and myalgia (3%, 1%).
The following spontaneous adverse events have been reported during the mar-
keting of desloratadine: tachycardia, and rarely hypersensitiyity reactions (such as
rash, pruritus, urticaria, edema, dyspnea, and anaphylaxis), and elevated liver
enzymes including bilirubin.
DRUG ABUSE AND DEPENDENCE: There is no information to indicate that abuse
or dependency occurs with CLARINEX Tablets.
OVERDOSAGE: Information regarding acute overdosage is limited to experience
from clinical trials conducted during the development of the CLARINEX product. In
a dose ranging trial, at doses of 10 mg and 20 mg/day somnolence was reported.
Single daily doses of 45 mg were given to normal male and female volunteers for
10 days. All ECGs obtained in this study were manually read in a blinded fashion by
a cardiologist. In CLARINEX-treated subjects, there was an increase in mean heart
rate of 9.2 bpm relative to placebo. The QT interval was corrected for heart rate
(QTC) by both the Bazett and Fridericia methods. Using the QTC (Bazett) there was a
mean increase of 8.1 msec in CLARINEX-treated subjects relative to placebo. Using
QTC (Fridericia) there was a mean increase of 0.4 msec in CLARINEX-treated sub-
jects relative to placebo. No clinically relevant adverse events were reported.
In the event of overdose, consider standard measures to remove any unabsorbed
drug. Symptomatic and supportive treatment is recommended. Desloratadine and
3-hydroxydesloratadine are not eliminated by hemodialysis.
Lethality occurred in rats at oral doses of 250 mg/kg or greater (estimated deslor-
atadine and desloratadine metabolite exposures were approximately 120 times the
AUC in humans at the recommended daily oral dose). The oral median lethal dose
in mice was 353 mg/kg (estimated desloratadine exposures were approximately
290 times the human daily oral dose on a mg/m2 basis). No deaths occurred at oral
doses up to 250 mg/kg in monkeys (estimated desloratadine exposures were
approximately 810 times the human daily oral dose on a mg/m2 basis).
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StatKit
Our Flagship Kit for
Aviation/Aerospace Medicine
3 WAYS TO ORDER OR GET MORE INFORMATION:
TOLL FREE 800-351-4530 or Internet www.BanyanAero.com or FAX 915-677-1372
Stat Kit 700
in Wack polyethylene case
Dimensions:
6 1/8" x 15 1/4" x 19 7/8"
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Harmonization and 'CAMA
Sunday' May 5, 2002
BY JAMES RL ALMAND, MD
Is the choir still out of tune? Hats off to your CAMA
President for:
4 A joint meeting with AsMA in Montreal
* A "CAMA Sunday" at AsMA 2002, Montreal
4 An outstanding international speakers' panel
program on aviation medical flight standards
harmonization.
The international panel was chaired by former
CAMA president Dr. John (Jack) Hastings, and his in-
troductory remarks commented favorably on the oc-
currence of this CAMA Sunday being developed under
CAMA sponsorship.
In this first-ever CAMA-sponsored panel, four in-
ternational authorities on world-wide pilot examina-
tion standards presented the current remarkable progress
in "harmonization" of requirements for flight medical
examinations of all classes of pilots and the process be-
ing made in all countries toward unity. If you missed
AsMA (and CAMA Sunday) in Montreal, regrets, for
the panel of...
4 Portugal's Francisco Braz de Oliveira, MD
* Netherlands's Annetje Roodenburg, MD
* Canada's Hugh O'Neill
4 Portugal's Francisco Braz de Oliveira, MD
* United States' Warren Silberman, DO
...clearly brought together a well-planned program
exhibiting the closeness of today's variable international
flight physical standards.
In addition, the audience was briefed on current,
world-wide differences regarding issues such as fre-
quency of exams, testing requirements, "social climates,"
and varied levels (i.e., classes) of physical examinations
in various countries. International views on laboratory,
EEG/ECG testing, age limits, and the AME/Family
Doctor responsibility for various levels of pilot exams
were clearly explained.
In all, the panel's four-hour program was so well re-
ceived by the audience that a uniform feeling suggested
that more updating (annual CAMA Sundays) to report
on standardization/unification/harmonization of flight
medical standards would be appreciated.
After all, it did take between 10 and 199 years for the
harmonized "Euro Dollar" to finally appear! Medicine
cannot be that far out of tune. fp
New Members (continued)
Neal Mogk, MD
715 North Beaver Street
Flagstaff, AZ 86001-3141
P- 928-774-7345
Family Practice AME
Fred Mosley, MD
2700 Farmington Avenue
Farmington, NM 87401-4559
P- 505-325-1100 F-505-325-5044
Family Practice AME
Kathryn R. O'Donnell, MD
1230 For Wood Drive
Fayetteville, NC 28301-7228
P-910-860-0743
Aviation Medicine AME
Oleg Olshanetskiy, DO
JFK Int. Airport, Bldg. #198
Jamaica, NY 11430-1814
P-718-656-5344
Aviation Medicine
Suzanne Parke, DO
695 Bocage Lane
Manderville, LA 70471-1605
p. 985-845-2326
Family Practice
AME
Anita Gayle Rogers, MD
KY Occupational Medicine
505 Shoppers Drive, Suite S
Winchester, KY 40391-2808
P- 859-737-3911 F- 859-737-9511
Occupational Medicine AME
Michael J. Rosser, MD
La Romanetteri Rue De la Vallee
St. Helier, Jersey JE2 3FA,
British, Channel Islands, UK
P-44-0-1534-863916
Family Practice AME
Spence Ian Rozin, MD
600 Professional Drive, Suite 150
Lawrenceville, GA 30045-8717
P-707-995-0324 F-707-822-9240
Internal Medicine AME
Scott Singer, MD, MPH
8555 Sweet Valley Drive
Valley View, OH 44125-4254
P-216-328-2240 F-216-642-7717
Occupational Medicine AME
Surenda Sodhi, MD
Al Noor Hospital
Khalifa Street, P.O. Box 46713
Adu Dhabi, UAE
P-00971-2-6139242 F-00971-2-
6264440
Internal Medicine AME
Paul W Sokoloski, MD
1008 Dent Lane
Cumberland, MD 21502-3416
P- 301-724-2515 F-301-724-2515
Emergency Medicine Pilot, AME
John Turns, MD
4847 Hopyard, Suite 4193
Pleasanton, CA 94588-2778
P-925-327-7996 F-925-426-9947
Family Practice AME
Rodney E.L. Williams, MD
Long Street, P.O. Box 753
St. John's, Antigua
P-268-462-0527 F-268-462-0117
Aviation Medicine Pilot, AME
AME
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Safety Measures Taken in the 1927 Dole Race to Hawaii
The Race Was Called the 'Most Frantic Scramble for Fame and Money in Aviation
History/ Yet, Some Were Concerned for the Flyers' Safety
BY J. ROBERT DILLE, MD
ON MAY 21, 1927, Charles A. Lindberghthrilled the world when he completed the firstnonstop flight from New York to Paris, 3,625miles in 33 hours, 29l/2 minutes, solo, and
won the $25,000 Orteig Prize. A fervor for transatlantic
flight and competitive record setting resulted.
The Army Air Service, still smarting from the fa-
vorable publicity gained by the Navy when they flew
the Atlantic in an NC-4 in 1919, prepared for a first
flight across the Pacific, from Oakland to Wheeler
Field, Honolulu. The flight was made by Lts. Lester J.
Maitland and Albert E Hegenberger in a Fokker C-2
on June 28-29, 1927, in 25 hours, 51 minutes. They
received letters of commendation. Ernest L. Smith and
Emery Bronte completed the trip in a Travel Air Model
MA July 15, but, due to fog, radio failure and inabil-
ity to communicate with each other in flight, they
landed in a tree on Molokai.
After Harvard graduation, James Drummond Dole,
a member of a missionary family that "went forth to
do good and did well," went to Hawaii to visit his
cousin, the first territorial governor. He stayed, started
a plantation, prospered, became president of the Ha-
waiian Pineapple Company (the world's largest), owned
the island of Lanai and was considered a leading builder
of Hawaii. He worked hard for closer ties with the
mainland, growth of tourism and statehood.
Two days after Lindbergh's landing in Paris, two en-
terprising reporters from the Honolulu Star Bulletin sent
a cable to Dole in San Francisco suggesting a suitable
prize for a nonstop trans-Pacific flight from the mainland
("the one great area remaining for conquest") to promote
the pineapple industry and the Dole name.
Two days later, on May 25, 1927, the following item
appeared in the Star Bulletin:
James D. Dole, believing that Charles A. Lindbergh's
extraordinary feat in crossing the Atlantic is the fore-
runner of eventual trans-Pacific air transportation,
offers $25,000 to the first flier and $10,000 to the
second flier to cross from the North American con-
tinent to Honolulu in a non-stop flight within one
year after the year beginning August 12, 1927.
Dole stated early on that the contest
should cost no brave man either life or limb
... stated early on that the contest should
cost no brave man either life or limb
Mr. Dole, not the Hawaiian Pineapple Company,
would provide the prize money.
The date was selected as more conducive to
Lindbergh's entry in the Dole Race, but he declined.
The race that resulted has been called the most fran-
tic scramble for fame and money in aviation history.
Initial entrants included barnstormers with World War
I surplus aircraft not suitable for the flight, pilots who
could not arrange sponsorship or afford an adequate
aircraft costing around $15,000 and non-pilots who
planned to learn to fly and enter before the one-year
deadline. Several prominent Washington officials
praised Dole's offer and assured the public that some
fliers would complete the flight in the prescribed time.
Dole stated early on that the contest should cost no
brave man either life or limb. He realized some of the
dangers of the race. Therefore, the Honolulu chapter
of the National Aeronautics Association (NAA), the
American branch of the Federation Aeronautique
Internationale, was asked by Dole to work out all de-
tails and prepare a complete set of rules covering both
planes and pilots.
Dole wanted every precaution to be taken to pre-
vent occurrence of any serious mishaps. He specified
that entrants should have sufficient fuel including a
margin of safety for errors, some means of safely re-
maining afloat in case of coming down enroute, an
ample supply of food and water, sufficient flares for
location at night and consideration of restricting the
route to a steamship lane to facilitate rescue in the event
of engine failure. The Honolulu chapter of NAA pre-
pared aeronautical charts but pilots were not familiar
with their use or aware of their importance.
The fuel reserve was set at 15%, a magnetic com-
pass and an airspeed indicator were required and a ra-
dio was recommended. Pilots needed to demonstrate
dead reckoning skills or carry a trained navigator.
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Louis H. Bower, MD, the first Director of
Medical Service in the Aeronautics Branch
... wrote medical standards which became
effective in six weeks. Fifty-one AMEs
were designated by February 28, 1927
Editorials and articles appeared suggesting that the
race was fool hardy and dangerous, and could easily
become a fiasco. This perception was not helped by
three fatalities in accidents involving aircraft enroute
to Oakland.
A Bureau of Air Commerce was established under
Secretary of Commerce Herbert Hoover and Assistant
Secretary of Commerce for Air William P. MacCracken
by the Air Commerce
Act of 1926. Major
Clarence Young, a Yale
graduate and a combat
pilot, was selected to
head the Aeronautics
Branch. He undertook
writing regulations to
specify air worthiness re-
quirements for airplanes
and engines. (Louis H. Bower, MD, became the first
Director of Medical Service in the Aeronautics Branch
on November 16, 1926). He wrote medical standards
which became effective in six weeks. Fifty-one AMEs
were designated by February 28, 1927; 200 by June
30, 1927.
Young and two Bureau of Air Commerce inspectors
arrived August 6 to perform airworthiness inspections.
Young called in Lieutenant Commander Ben H. Wyatt
from North Island Naval Air Station, San Diego, to
assist the team. However, only one airplane was ready.
A delay in starting the race by four days, to August 16,
resulted. Most entries were disqualified (27); only eight
were found adequate for the race. Of these, two crashed
on take-off and two returned in less than one hour due
to mechanical problems. Only four were in flight after
one hour; a returnee restarted two days later and was
lost at sea. Only two reached Honolulu. A search by
65 Navy ships and hundreds of maritime vessels in-
cluding 120 sampans found no survivors or wreckage.
Seven lives were lost. No medical defects are known.
The Dole or Pacific Air Race has been
called the wildest air derby of them all.
Many considered Dole a publicity crazed
Pineapple King
The winners in the radio-equipped Travel Air,
Woolaroc, sponsored by Phillips Petroleum of
Bartlesville, OK, were movie stunt pilot Arthur Goebel
and his navigator U.S. Navy Lieutenant William J.
Davis, Jr. (a pilot on 30 days leave). They collected
$25,000. The only other finishers, Martin Jenson of
Honolulu and his navigator, Paul Schluter, collected
$10,000. When asked by reporters to demonstrate their
life raft, it failed.
The Dole or Pacific Air Race has been called the
wildest air derby of them all. Many considered Dole a
publicity crazed Pineapple King who was responsible
for the 10 deaths and the search costs because he put
up the bountiful prize money. There were rumors that
serious illness and an early death resulted. Actually he
died at age 81. He said that he felt some responsibility
but he turned over all
safety decisions to the
aeronautical authorities
(who ignored his recom-
mendations that each
plane have sending and
receiving radios).
Regular commercial
service to Hawaii began
eight years later. Tour-
ism eventually boomed. Statehood was achieved in
1959. One clear lesson that emerged was that aviation
would never expand until flying could be made more
dependable in all types of weather with the aid of avi-
onics. Assistant Secretary of Commerce for Air
MacCracken replied to criticism of government per-
mission for the race with "risks and hazards are an in-
herent part of any pioneering effort." He promised that
the Bureau of Air Commerce would do its best to in-
spect and regulate such aerial adventurers.
Clarence Young appears regularly in the histories of
Drs. Bauer, Cooper and Longacre. He rose rapidly.
Some documents are signed Clarence Young, Acting
Secretary of Commerce. He later headed the Pacific
Division for Pan American Airways where he hastened
Dole's dream of scheduled air service to Hawaii.
After Lindbergh's acclaimed flight in May 1927, the
Atlantic claimed 20 lives in seven months. Neither
Lindbergh nor Orteig was called responsible for these
deaths.
/P
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CIVIL AVIATION MEDICAL ASSOCIATION
Corporate and Sustaining Members
The financial resources of individual members alone cannot sustain the Association's pursuit of its broad goals
and objectives. Its forty-six year history is documented by innumerable contributions toward aviation health and
safety that have become a daily expectation by airline passengers worldwide. Support from private and commer-
cial sources is essential for CAMA to provide one of its most important functions: that of education. The follow-
ing support CAMA through corporate and sustaining memberships:
James R. Almand Jr., MD
Frank H. Austin Jr., MD
R.L. Bendixen, MD
Forrest M. Bird, MD, PhD
Stephen V.A. Blizzard, MD
Per-Johan Cappelen, MD
Frank J. Ceravolo, MD
Halford R. Conwell, MD
SUSTAINING MEMBERS
Gary E. Crump, PA.
Robin E. Dodge, MD
John D. Hastings, MD
Francis C. Hertzog, Jr. MD
Marlene K. Lambiaso, MD
Floyd E McSpadden, MD
Hugh O'Neill, MD
Robert W. Rigg, MD
Gordon L. Ritter, DO
W. David Rummel, MD
M. Young Stokes III, MD
James L. Tucker Jr., MD
H. Stacy Vereen, MD
Albert van der Waag, Jr., MD
Alex M. Wolbrink, MD
Banyan International Corp.
P.O. Box 1779
Abilene, TX 70604-1779
Continental Airlines
9900 Richmond Ave.
Houston, TX 77210-4807
Data Transformation Corp.
108-D Green tree Road
Turnersville, NJ 08012
HP Heartstream
2401 4th Ave., Suite 500
Seattle, WA 98121-1436
CORPORATE MEMBERS
Medaire, Inc
1301 E. McDowell Rd, #204
Phoenix, AZ 85006-2665
Motara Instruments, Inc.
7866 North 86th Street
Milwaukee, WI 53224
Nonin Medical Inc.
2605 Fernbrook Lane North
Plymouth, MN 55447-4755
Percussion Aire Corp.
Forrest M. Bird, MD, Pres.
Sandpoint, ID 83864-0817
Rummel Eye Care, PC.
1022 Willow Creek Rd.
Prescott, AZ 86301-1642
Schering Corporation
Kenilworth, NJ 0733
Stereo Optical Company Inc
Joseph F. Andera, President
Chicago, IL 60641
Titmus Optical
3311 Corporate Drive
Petersburg, VA 23805-9288
Voyager Air Center
Denison, TX
Harvey Watt & Co., Inc.
P.O. Box 20787
Atlanta, GA 30320
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Counterfeit Medications
BY STEPHEN H. GOODMAN, MD
"WHAT'S IN THAT PILL?" you ask the airman who is
showing it to you, as you take a history and prepare to
conduct the physical examination for an airman medi-
cal certificate?
The airman tells you that it is a medication bought
while overseas at a pharmacy in Macau, China, while
attending an international conference. The pill looks
right and has the right pharmaceutical markings. You
look it up in your recent PDR and identify it as the
sleep medication Ambien.
But are you sure? And how do you check on the
ingredients in the pill so you can advise your airman
that it is safe to take?
You look it up again in the current edition of
Martindales, you identify the preparation and it looks
okay, but there is something in your "minds eye" that
makes you uncertain. What to do?
It's the perfect crime. Counterfeit medicines that
look real and are impossible to tell the difference be-
tween the real thing and the fake! They are hard to
identify, and difficult to track down and determine
where they came from. When you counterfeit a CD or
a videotape it does not have a health impact. It just
means that Microsoft or Sony Pictures won't get royal-
ties. But to subject unsuspecting individuals to the
hands of criminals can leave your airman seriously ill
and even lead to death and possibly impact the Na-
tional Airspace System.
Counterfeit preparations have shown up in China,
Guangxi Province, last October, where a traditional
Chinese medicine was laced with an expired Western
antibiotic that resulted in the serious illness of 70 pa-
tients who took the preparation. In the 1990s, a mul-
tinational Philippine drug company discovered the
counterfeiting of its asthma inhalers. In India, the In-
dian Pharmaceutical Alliance estimates that 20% of
the drugs on the market in India are fake and that for
certain brands the rate may be as high as 35-40%.
Obviously this is a multinational issue with cross-
border networks and implications. The US House of
Representatives' Energy and Commerce Committee has
indicated that there is some evidence that this trade
has connections with terrorism.
What is being done about this emerging health is-
sue? The prime responsibility for prevention and control
of counterfeiting medication resides with government
regulation and the healthcare infrastructure. The World
Health Organization collects information on the inci-
dence of counterfeiting and provides guidance to those
governments on measures to take to counteract the
problem. Members of the pharmaceutical industry are
taking action internationally to collect, analyze, and
inform governments and international agencies about
this covert activity in their respective areas of the world.
So what does this mean to you—the aviation medi-
cal examiner—and the National Airspace System? As
globalization hits home in your local communities and
your individual medical practices, the threat of coun-
terfeit medications becomes more of reality to manage.
Know who you are examining, not only for an air-
man medical certificate but for general medical care as
well.
Take a good history, especially from the airman who
travels internationally, and ask about medical prepara-
tions purchased abroad.
Inspect the medication that the individual is tak-
ing, and be circumspect if the package has an abnor-
mal appearance or the contents do not look uniform.
And finally, do not hesitate to ask where the medi-
cation came from and the purpose of its use by the
individual.
If you are uncertain about who you are examining
and medicinal preparations being used, then take the
time to call your respective health agency for guidance.
This will ensure that you take the appropriate action
and safeguard the integrity of the National Airspace
System. fP
Dr. Goodman is the Regional Flight Surgeon of the Fed-
eral Aviation Administration's Western Pacific Region.
Visit CAMA's Web Site
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Suggestions and contributions
are welcome, so visit the site
and give us your opinions.
n The Horizon
Annual Scientific Meeting
The Civil Aviation Medical Association's Annual Scien-
tific Meeting will be held in Amsterdam, the Netherlands, on
October 9-13,2002.
There will be an in-depth look at the role of aircraft as a
disease vector. The program's objective is to assess the epide-
miology of specific infectious diseases in aircraft travel: cos-
mic radiation and aircrew safety, cabin air quality, deep vein
thrombosis and air travel, zoonotic risks of air transportation
of animals, hepatitis in travelers, and bioterrorism.
The Netherlands Society of Aviation Medicine will host
the CAMA meeting. The Mayor of Amsterdam will host the
attendees at a reception at City Hall on Wednesday evening.
There will be a grand tour of the Aeromedical Insti tute
Soesterberg, with demonstrations of the human centrifuge,
hypobaric chambers, and spatial disorientation. Tours of the
area will be included each afternoon with a farewell canal
cruise on Saturday evening.
This is a program you and the family don't want to miss.
To register for this exciting program contact:
• CAMA Headquarters at (405) 840-0199 or
• Bas Voorsluijs, Seelstraat 69, Utrecht, the Netherlands at
+31 302884317
CAMA Headquarters
P.O. Box 23864
Oklahoma City, OK 73123-2864
FAA Aviation Medical Examiner
Seminar Schedule
2002
July 12-14 Bellevue, Wash. (Neuro/ Psychol/Psy)
August 16-18 McLean, Va. (Aviation Physiology/Human
Factors
September 9-13 Oklahoma City, Okla. (Basic)
December 2-6 Oklahoma City, Okla. (Basic)
2003
January 10-12 Phoenix, Ariz. (Cardiology)
March 10-14 Oklahoma City, Okla. (Basic)
April 25-27 Atlanta, Ga. (Ophth/Otolaryn/Endocrin)
For information, call your regional flight surgeon. To schedule
a seminar, call the FAA Civil Aerospace Medical Institute
AME Programs Office ( 405) 954-4830
Visit CAMA's Web Site: www.civilavmed.com
